Literature DB >> 9443422

Monitoring platelet GP IIb/IIIa antagonist therapy.

B S Coller1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9443422     DOI： 10.1161/01.cir.97.1.5

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  8 in total

Review 1.  Glycoprotein IIb/IIIa receptor antagonists: clinical pharmacology in cardiovascular diseases of aging.

Authors:  M Sebastian; R Makkar
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

2.  Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty.

Authors:  K M Akkerhuis; M J van Den Brand; C van Der Zwaan; H O Peels; H Suryapranata; L R van Der Wieken; J Stibbe; J Hoffmann; T Baardman; J W Deckers; M L Simoons
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

Review 3.  Anti-platelet therapy: glycoprotein IIb-IIIa antagonists.

Authors:  David J Schneider
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

4.  Efficacy of abciximab induced platelet blockade using a rapid point of care assay.

Authors:  D J Kereiakes; M Mueller; W Howard; P Lacock; L C Anderson; T M Broderick; E M Roth; D D Whang; C W Abbottsmith
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

5.  Abciximab and left ventricular thrombus formation in early period of acute myocardial infarction treated with successful primary stenting.

Authors:  Marzenna Zielinska; Krzysztof Kaczmarek
Journal:  J Thromb Thrombolysis       Date:  2008-05-04       Impact factor: 2.300

6.  Translational research: forging a new cultural identity.

Authors:  Barry S Coller
Journal:  Mt Sinai J Med       Date:  2008-10

Review 7.  Abciximab. An updated review of its use in ischaemic heart disease.

Authors:  R H Foster; L R Wiseman
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

8.  Thromboelastography detects inadequate response to abciximab therapy during stent-assisted cerebral aneurysm coil embolization complicated by stroke.

Authors:  Frederick W Lombard; Ian J Welsby; Michael J Alexander; Cecil O Borel
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.